Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm characterized by the presence of benign epithelial and myoepithelial cells and a mesenchymal component that may contain mucoid, myxoid, cartilaginous, or osseous areas. It may be completely or partially encapsulated. It occurs in the parotid gland, submandibular gland, minor salivary glands in the oral cavity, upper respiratory tract, and nasal cavity and paranasal sinuses. It usually presents as a slow growing painless mass. Infrequently, patients may present with pain and facial palsy. It may recur after excision or transform to a malignant neoplasm (carcinoma ex pleomorphic adenoma).
Features include: Salivary gland neoplasm.
PLAG1 function has not been fully characterized.
Pleomorphic adenoma is associated with mutations in the PLAG1 gene on chromosome 8.
Genetic testing for PLAG1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for pleomorphic adenoma has been reported in the published literature.
1 clinical trial registered. Pipeline includes 1 PHASE2.
316 publications have been identified in PubMed for pleomorphic adenoma. Kisho has analyzed 105 by research type. Research spans Case Report / Case Series (32%), Review / Meta-Analysis (23%), and Basic Science / Preclinical (23%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 34 | 32% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 11:21 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
24 |
23% |
Laboratory research | 24 | 23% |
Testing and diagnosis research | 9 | 9% |
Disease patterns and progression | 8 | 8% |
Clinical study results | 3 | 3% |
Other research | 2 | 2% |
New treatment approaches | 1 | 1% |
Harbaj S (2026). [PMID: 41869238](https://pubmed.ncbi.nlm.nih.gov/41869238/). *Cureus*. [Case Report / Case Series]
Fayaz Y (2026). [PMID: 41907573](https://pubmed.ncbi.nlm.nih.gov/41907573/). *Int Med Case Rep J*. [Case Report / Case Series]
Lian J (2026). [PMID: 41869656](https://pubmed.ncbi.nlm.nih.gov/41869656/). *Front Oncol*. [Case Report / Case Series]
Meckley AL (2026). [PMID: 39536142](https://pubmed.ncbi.nlm.nih.gov/39536142/). *Unknown Journal*. [Diagnostic / Biomarker]
Young A (2026). [PMID: 33231965](https://pubmed.ncbi.nlm.nih.gov/33231965/). *Unknown Journal*. [Case Report / Case Series]
Young A (2026). [PMID: 33079504](https://pubmed.ncbi.nlm.nih.gov/33079504/). *Unknown Journal*. [Review / Meta-Analysis]
Abend A (2026). [PMID: 41159249](https://pubmed.ncbi.nlm.nih.gov/41159249/). *Laryngoscope*. [Other]
Mwakitwange A (2026). [PMID: 42078166](https://pubmed.ncbi.nlm.nih.gov/42078166/). *J Surg Case Rep*. [Case Report / Case Series]
Duplessis W (2026). [PMID: 41650795](https://pubmed.ncbi.nlm.nih.gov/41650795/). *Semin Diagn Pathol*. [Review / Meta-Analysis]
Dogan R (2026). [PMID: 41549870](https://pubmed.ncbi.nlm.nih.gov/41549870/). *Clin Otolaryngol*. [Diagnostic / Biomarker]